Comparison

Ro5-3335 European Partner

Item no. TMO-T4687-2mg
Manufacturer TargetMol
CASRN 30195-30-3
Amount 2 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 1 mg 200 mg 25 mg 2 mg 50 mg 5 mg
Category
Type Chemicals
Specific against other
Formula C13H10ClN3O
Smiles Clc1ccc2NC(=O)CN=C(c3ccc[nH]3)c2c1
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Alias CBFβ-Runx1 inhibitor II,Ro 5-3335
Shipping Condition Cool pack
Available
Manufacturer - Targets
DNA/RNA Synthesis
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
259.69
Description
Ro5-3335 (CBFβ-Runx1 inhibitor II) is core binding factor (CBF) inhibitor; preferentially kills human leukemia cell lines with CBF fusion proteins (IC50 = 1.1 μM). Ro5-3335 represses RUNX1/CBFβ-dependent transactivation in reporter assays and inhibits transcriptional regulation by RUNX1 and CBFβ. Ro5-3335 also reduces the leukemia burden in a mouse model. Attenuates RUNX1-dependent hematopoiesis in zebrafish embryos. It also is a Tat antagonist and inhibits HIV-1 replication in vitro.
Pathways
DNA Damage/DNA Repair|||Cell Cycle/Checkpoint
Bioactivity
Ro 5-3335 is core binding factor (CBF) inhibitor; preferentially kills human leukemia cell lines with CBF fusion proteins (IC50 = 1.1 μM). It represses RUNX1/CBFβ-dependent transactivation in reporter assays and inhibits transcriptional regulation by RUNX

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 2 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close